Inhibited colitis by promoting polarization to an anti-inflammatory phenotype, as evidenced by increased Arg1 and Fizz1 markers. Increased IL-10 and TGFβ, and decreased IL-6 and TNF. This evidence concerns the gene RETNLB and colitis.